XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Sep. 30, 2021
Current assets    
Cash and equivalents $ 11,442,487 $ 15,426,976
Restricted cash 1,518,720 1,759,347
Short-term investments 280,571 14,981
Trade receivables, net 7,564,382 7,810,896
Trade receivables - related party 1,472,514 1,487,155
Inventory –net of allowance for inventory obsolescence 8,458,530 5,657,287
Prepaid expenses and other assets 2,407,116 2,585,652
Total current assets 33,144,320 34,742,294
Property and equipment, net 6,239,239 6,738,944
Right-of-use assets 2,641,960 2,940,127
Goodwill 7,821,283 7,821,283
Other 1,356,766 697,240
Total Assets 51,203,568 52,939,888
Current liabilities    
Accounts payable 5,401,538 4,235,002
Short-term liabilities 17,146,234 9,977,972
Lease liabilities - short-term 819,488 830,791
Deposits from customers 113,106 536,220
Accrued expenses 1,176,787 1,621,053
Deferred revenue 2,594,517 2,004,170
Accrued income taxes 141,465 448,194
Total current liabilities 27,393,135 19,653,402
Long-term liabilities    
Loans payable to bank 141,239 767,279
Long-term lease liabilities 1,799,002 2,017,408
Notes payable 228,893 2,350,000
Mortgage payable 2,184,404 2,257,785
Other long-term liabilities 825,629 839,171
Paycheck Protection Program Loans 97,120 1,032,200
Deferred Revenue - long-term 584,003 467,967
Total long-term liabilities 5,860,290 9,731,810
Total liabilities 33,253,425 29,385,212
Commitments and contingencies
Shareholders’ equity    
Common stock, $0.001 par value, 50,000,000 shares authorized, 26,263,296 shares issued and outstanding at June 30, 2022 and 20,782,194 shares issued and outstanding at September 30, 2021 26,263 20,782
Additional paid-in capital 66,522,085 61,727,834
Retained earnings (accumulated deficit) (51,788,053) (41,908,062)
Treasury stock at cost (148,291) (148,291)
Accumulated other comprehensive income (loss) 2,555,441 2,896,452
Total Cemtrex stockholders’ equity 17,169,574 22,590,650
Non-controlling interest 780,569 964,026
Total liabilities and shareholders’ equity 51,203,568 52,939,888
Series1 Preferred Stock [Member]    
Shareholders’ equity    
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at June 30, 2022 and September 30, 2021 2,079 1,885
Series C Preferred Stock [Member]    
Shareholders’ equity    
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at June 30, 2022 and September 30, 2021 $ 50 $ 50